Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | ATXS | CRVS | ||
| Company | Urovant Sciences Ltd | Astri Therapeutics Inc | Corvus Pharma Com | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 9.61 | 8.24 | ||
| High | 16.24 | 9.83 | 8.99 | ||
| Low | 16.21 | 9.20 | 8.04 | ||
| Last | 16.24 | 9.53 | 8.96 | ||
| Change | +0.01 | -0.05 | +0.72 | ||
| % Change | +0.06% | -0.52% | +8.74% | ||
| Volume | 1,739,000 | 81,064 | 551,517 | ||
| 20-Day Average Volume | 143,510 | 232,802 | 1,030,329 | ||
| Previous Close | 16.23 | 9.58 | 8.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 10.99 | 8.78 | ||
| 20-Day Raw Stochastic | 87.10% | 26.63% | 54.87% | ||
| 20-Day Relative Strength | 65.56% | 39.87% | 62.41% | ||
| Weighted Alpha | +6.45 | +31.95 | +469.08 | ||
| Today's Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 80% Buy | ||
| Last Month's Opinion | 96% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -4.36% since 11/14/24 | +5.40% since 11/14/24 | ||
| Low | 16.20 on 03/24/21 | 8.61 on 11/18/24 | 7.78 on 11/15/24 | ||
| High | 16.25 on 03/25/21 | 10.17 on 11/15/24 | 8.99 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -14.30% since 10/21/24 | +18.78% since 10/21/24 | ||
| Low | 16.10 on 03/02/21 | 8.61 on 11/18/24 | 7.03 on 10/23/24 | ||
| High | 16.26 on 03/19/21 | 12.52 on 10/30/24 | 10.00 on 11/13/24 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -19.11% since 08/21/24 | +116.39% since 08/21/24 | ||
| Low | 16.03 on 12/30/20 | 8.61 on 11/18/24 | 3.87 on 08/26/24 | ||
| High | 16.26 on 03/19/21 | 12.92 on 09/20/24 | 10.00 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +4.89% since 05/21/24 | +311.93% since 05/21/24 | ||
| Low | 7.15 on 11/02/20 | 8.59 on 05/29/24 | 1.75 on 07/05/24 | ||
| High | 16.26 on 03/19/21 | 12.92 on 09/20/24 | 10.00 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 540,638 | 529,478 | ||
| Shares Outstanding, K | 32,743 | 56,434 | 64,257 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -146,750,000 | -72,890,000 | -27,030,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -46,800,000 | -24,530,000 | -40,220,000 | ||
| 60-Month Beta | 2.35 | 0.71 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.42 on 11/13/24 | -0.11 on 11/12/24 | ||
| Latest Earnings Date | 02/11/21 | 11/11/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||